(Q37918433)

25 August 2017

1 reference

title

Drug therapy of post-stroke aphasia: a review of current evidence (English)

1 reference

25 August 2017

1 reference

Friedemann Pulvermüller

2

object named as

Friedemann Pulvermüller

0 references

author name string

Marcelo L Berthier

1

1 reference

25 August 2017

Guadalupe Dávila

3

1 reference

25 August 2017

Natalia García Casares

4

1 reference

25 August 2017

Antonio Gutiérrez

5

1 reference

25 August 2017

publication date

16 August 2011

1 reference

25 August 2017

published in

Neuropsychology Review

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

302-317

1 reference

Pharmacotherapy for aphasia

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Drugs and recovery: a challenge for a few?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Galantamine treatment of vascular dementia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The impact of neuropsychological deficits on functional stroke outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Amantadine for adynamic speech: possible benefit for aphasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pharmaceuticals for poststroke and brain injury rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Age and evolution of language area functions. A study on adult stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aphasia burden to hospitalised acute stroke patients: need for an early rehabilitation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Poststroke aphasia : epidemiology, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neuroscience insights improve neurorehabilitation of poststroke aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Open-label study of donepezil in chronic poststroke aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A randomized, placebo-controlled study of donepezil in poststroke aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Effect of propranolol on naming in chronic Broca's aphasia with anomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Intensity of Aphasia Therapy, Impact on Recovery * Aphasia Therapy Works!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Behavioral and neurophysiologic response to therapy for chronic aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

EFNS guidelines on cognitive rehabilitation: report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Rehabilitation after stroke: current state of the science.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Evidence-based systematic review: effects of intensity of treatment and constraint-induced language therapy for individuals with stroke-induced aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Epidural cortical stimulation as adjunctive treatment for non-fluent aphasia: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cholinergic augmentation modulates visual task performance in sleep-deprived young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Multifactorial processes in recovery from aphasia: developing the foundations for a multileveled framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Transient improvement of aphasia with zolpidem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Repairing the human brain after stroke. II. Restorative therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neuroplasticity and brain repair after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Recovery and treatment of aphasia after stroke: functional imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Role of the right and left hemispheres in recovery of function during treatment of intention in aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cortical Surface-Based Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pharmacotherapy of aphasia: myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Incidence and profile of inpatient stroke-induced aphasia in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Strategies for stroke rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Improving outcome after stroke: overcoming the translational roadblock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Age and type of aphasia in patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Effects of donepezil on verbal memory after semantic processing in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neural correlates of phonological and semantic-based anomia treatment in aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Transcranial magnetic stimulation (TMS): potential progress for language improvement in aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Amphetamine trials and tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Mechanisms underlying perseveration in aphasia: evidence from a single case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Functional plasticity in cognitive aging: review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cholinergic enhancement of episodic memory in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Bromocriptine treatment of nonfluent aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A proposed regional hierarchy in recovery of post-stroke aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pharmacological, surgical, and neurovascular interventions to augment acute aphasia recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The role of piracetam in the treatment of acute and chronic aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Improved optimization for the robust and accurate linear registration and motion correction of brain images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Galantamine in frontotemporal dementia and primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Can drug therapies improve language functions of individuals with aphasia? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Levodopa: faster and better word learning in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Predicting the outcome of anomia therapy for people with aphasia post CVA: both language and cognitive status are key predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aphasia in acute stroke and relation to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Variability in recovery from aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Improvement in aphasia scores after stroke is well predicted by initial severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aging cognition: from neuromodulation to representation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pharmacotherapy in restorative neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Widening the temporal window: processing support in the treatment of aphasic language production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Poststroke dementia in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Blocking the deadly effects of the NMDA receptor in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Drugs for stroke recovery: the example of amphetamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Ambient experience in restitutive treatment of aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Memantine: a review of its use in moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neuropharmacology of verbal perseveration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Long-term stability of improved language functions in chronic aphasia after constraint-induced aphasia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Intensive language training in the rehabilitation of chronic aphasia: efficient training by laypersons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Recent developments in functional and structural imaging of aphasia recovery after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Imaging short- and long-term training success in chronic aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cholinergic denervation in a pure multi-infarct state: observations on CADASIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Improved language in a chronic nonfluent aphasia patient after treatment with CPAP and TMS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neuropharmacological modulation of cognitive deficits after brain damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aphasia after stroke: type, severity and prognosis. The Copenhagen aphasia study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Predicting language outcome and recovery after stroke: the PLORAS system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aphasia therapy on a neuroscience basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Constraint-induced therapy of chronic aphasia after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Treatment of adynamia in aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Effects of bromocriptine in a patient with crossed nonfluent aphasia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Donepezil in vascular dementia: combined analysis of two large-scale clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

An open-label trial of bromocriptine in nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Dynamics of language reorganization after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Amantadine enhancement of arousal and cognition after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

New approach to the rehabilitation of post-stroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Choline acetyltransferase activity in vascular dementia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Nucleus subputaminalis (Ayala): the still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Biological approaches to aphasia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Fast robust automated brain extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Neurological signs in relation to type of cerebrovascular disease in vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

White matter NMDA receptors: an unexpected new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Effects of increased cholinergic activity on naming in aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The effects of the glutamate antagonist memantine on brain activation to an auditory perception task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The long-term efficacy and tolerability of donepezil in patients with vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Piracetam: a review of pharmacological properties and clinical uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Donepezil and flight simulator performance: effects on retention of complex skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The use of cueing to alleviate recurrent verbal perseverations: Evidence from transcortical sensory aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Aphasia severity, semantics, and depression predict functional communication in acquired aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

A process for translating evidence-based aphasia treatment into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Prognosis for aphasia: Relationship between selected biographical and behavioural variables and outcome and improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

The incidence of cases of aphasia following first stroke referred to speech and language therapy services in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Pharmacological approaches to the treatment and prevention of aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

What is aphasia? Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Epidemiology of Aphasia Attributable to First Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11065-011-9177-7

Changes in language-specific brain activation after therapy for aphasia using magnetoencephalography: a case study

21 January 2018

1 reference

12 December 2020

Neuropharmacology and linguistic neuroplasticity

1 reference

12 December 2020

Task-dependent changes in brain activation following therapy for nonfluent aphasia: discussion of two individual cases

1 reference

12 December 2020

Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia

1 reference

12 December 2020

Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection

1 reference

12 December 2020

The changing view of neurorehabilitation: a new era of optimism

1 reference

12 December 2020

Speech and language therapy for aphasia following stroke

1 reference

12 December 2020

A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke

1 reference

12 December 2020

Functional re-recruitment of dysfunctional brain areas predicts language recovery in chronic aphasia

1 reference

12 December 2020

NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia

1 reference

12 December 2020

Pharmacological treatment for aphasia following stroke

1 reference

12 December 2020

Predictors of language restitution following stroke: a multivariate analysis

1 reference

12 December 2020

1 reference

12 December 2020

Significance of aphasia after first-ever acute stroke: impact on early and late outcomes

1 reference

12 December 2020

Therapy efficacy in chronic aphasia

1 reference

12 December 2020

Effects of bifemelane hydrochloride on cerebral circulation and metabolism in patients with aphasia.

1 reference

12 December 2020

Crossover Trial of Subacute Computerized Aphasia Therapy for Anomia With the Addition of Either Levodopa or Placebo

1 reference

12 December 2020

Aphasia in acute stroke: incidence, determinants, and recovery

1 reference

12 December 2020

Variability in language recovery after first-time stroke

1 reference

12 December 2020

Hemispheric asymmetry reduction in older adults: the HAROLD model

1 reference

12 December 2020

Use of amphetamine in the treatment of aphasia

1 reference

12 December 2020

Outcome of a one-month therapy intensive for chronic aphasia: variable individual responses

1 reference

12 December 2020

Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?

1 reference

12 December 2020

Physostigmine for Alzheimer's disease

1 reference

12 December 2020

Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery

1 reference

12 December 2020

Using transcranial direct-current stimulation to treat stroke patients with aphasia

1 reference

12 December 2020

Effects of cholinergic blockade on language in healthy young women

1 reference

12 December 2020

The efficacy of donepezil for post-stroke aphasia: a pilot case control study

1 reference

12 December 2020

Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke

1 reference

12 December 2020

Psychophysiological analysis of the influence of vasopressin on speech in patients with post-stroke aphasias.

1 reference

12 December 2020

Cerebrolysin for acute ischaemic stroke

1 reference

12 December 2020

Dexamphetamine boosts naming treatment effects in chronic aphasia

1 reference

12 December 2020

Impact of aging on cerebral vasoregulation and parenchymal integrity

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia

1 reference

12 December 2020

Consensus document on European brain research

1 reference

12 December 2020

Bromocriptine treatment of nonfluent aphasia

1 reference

12 December 2020

Impairments of procedures for implementing complex language are due to disruption of frontal attention processes

1 reference

12 December 2020

10.1007/S11065-011-9177-7

Identifiers

DOI

1 reference

25 August 2017

1 reference